Copper-binding tripeptide (cosmetic / hair research)
AHK copper
A copper-complexed tripeptide studied mainly in cosmetic and follicle research; human clinical evidence remains limited.
- Evidence:
- Insufficient evidence summarized
- Status:
- Research-stage
- Reviewed:
- 2026-08-03
Also known as: AHK copper, Ala-His-Lys-Cu
What is AHK copper?
A copper-complexed tripeptide studied mainly in cosmetic and follicle research; human clinical evidence remains limited.
This profile is educational. It organizes publicly discussed research context for AHK copper and related naming aliases — it is not a treatment guide.
Proposed mechanism
Proposed to modulate extracellular matrix remodeling and follicular signaling via copper-dependent enzymatic pathways.
Mechanism language on PepGuide describes how researchers discuss pathways. Proposed mechanisms can change as evidence evolves.
Current research notes
Human evidence grade: Insufficient evidence summarized
Preclinical evidence grade: Early-stage human research
AHK-Cu is discussed alongside GHK-Cu in cosmetic peptide literature. Available evidence is largely preclinical or small cosmetic studies. Not FDA approved as a drug.
Key uncertainties
- Magnitude of human cosmetic or hair effects
Research areas being studied
- Cosmetic dermatology
- Hair follicle research
Being studied for a topic is not the same as proven benefit in that topic. Prefer primary literature for study design, endpoints, and limitations.
Safety & side-effect notes
Reported or discussed adverse effects
- Insufficient systematic human data
Additional risks & considerations
- Unregulated product quality
- Limited safety datasets
Regulatory status
Research-stage
Regulatory framing here is educational and can lag policy changes. Check official sources for current status.
Frequently asked questions
What is AHK copper?
A copper-complexed tripeptide studied mainly in cosmetic and follicle research; human clinical evidence remains limited.
How does AHK copper work (proposed mechanism)?
Proposed to modulate extracellular matrix remodeling and follicular signaling via copper-dependent enzymatic pathways.
What is AHK copper being researched for?
AHK copper has been discussed in research contexts including: Cosmetic dermatology, Hair follicle research.
What does current evidence say about AHK copper?
Insufficient evidence summarized. AHK-Cu is discussed alongside GHK-Cu in cosmetic peptide literature. Available evidence is largely preclinical or small cosmetic studies. Not FDA approved as a drug.
What safety considerations are noted for AHK copper?
Reported or discussed considerations include: Insufficient systematic human data; Unregulated product quality; Limited safety datasets. This is educational information, not medical advice.
References & sources
- Multiple authors (2018). Copper peptides in skin and hair research — Cosmetics. Evidence type: review.
Prefer interactive tools? Open the PepGuide library entry for AHK copper or ask PepGuide AI.
Educational and research information only. PepGuide does not sell or prescribe peptides, diagnose conditions, or provide personalized medical advice. Evidence summaries may include early-stage, animal, or limited human research — none of that is a substitute for primary literature or clinician guidance.